NASDAQ:AARD | Income Statement | Aardvark Therapeutics, Inc.

Complete source-backed income-statement history.

Available history
2024-03-31 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$10.46M$15.08M-$15.08M$697,000.00-$14.39M-$0.66-$0.6621,846,25121,846,251
2026-03-31$0.00$16.57M$22.46M-$22.46M$876,000.00-$21.59M-$0.99-$0.9921,815,99521,815,995
2025-12-31$0.00$14.3M$18.7M-$18.7M$1.11M-$17.6M-$0.81-$0.81727,137727,137
2025-09-30$13.74M$17.7M-$17.7M$1.39M-$16.32M-$0.75-$0.7521,713,85821,713,858
2025-06-30$13.15M$15.85M-$15.85M$1.48M-$14.37M-$0.66-$0.6621,690,27521,690,275
2025-03-31$0.00$7.76M$10.47M-$10.47M$1.16M-$9.31M-$0.71-$0.7113,194,71813,194,718
2024-12-31$8.06M$9.45M-$9.45M$671,000.00-$8.78M-$2.18-$2.1822,22422,224
2024-09-30$4.07M$5.09M-$5.09M$909,000.00-$4.18M-$1.05-$1.053,986,9973,986,997
2024-06-30$4.03M$6.07M-$6.07M$624,000.00-$5.45M-$1.37-$1.373,967,9843,967,984
2024-03-31$1.21M$2.17M-$2.17M-$7,000.00-$2.18M-$0.55-$0.553,967,3333,967,333

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31$0.00$48.94M$62.73M-$62.73M$5.13M$0.00-$57.59M-$2.93-$2.9319,624,62619,624,626
2024-12-31$17.36M$22.79M-$22.79M$2.2M$0.00-$20.59M-$5.15-$5.153,996,3763,996,376